| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.035 | 0.4 |